Treat, Prevent, Restore: Sensorion’s Approach To Hearing Loss

French Biotech Is Developing Small Molecules And Gene Therapies

21 Dec 2023

Hearing loss lacks pharmacological treatment options, with patients instead relying on medical devices or going untreated. In Vivo spoke to French biotech Sensorion, which is targeting a number of hearing loss indications with small-molecule drugs and gene therapies.

Adult woman and young girl conversing in sign language at a playground — • Source: Shutterstock

A lack of approved pharmacological therapies for hearing loss, whether acquired or congenital, is a gap in the market that a number of biotechs and big pharmaceutical firms are looking to plug. While medical devices such as hearing aids or cochlear implants can be a boon for patients who are deaf or hard of hearing, a lack of drug treatment options represents a significant unmet medical need.

“The biological approaches a patient needs are very different” depending on whether their hearing loss can be treated or prevented,...